Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy

Journal of Radiation Research

Volumn 53, Issue 6, 2012, Pages 916-922

  Ozgen, Aytul ^a   Hayran, Mutlu ^b   Kahraman, Fatih ^c  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Sanatoryum Hastanesi   (Turkey)

Author keywords

acute esophagitis; concurrent chemotherapy; dosimetric parameters; lung cancer; radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASES; DOSIMETRY; PATIENT MONITORING; TOXICITY;

ACUTE ESOPHAGITIS; CANCER PATIENTS; CONCURRENT CHEMOTHERAPY; DOSIMETRIC PARAMETER; ESOPHAGEAL TOXICITIES; ESOPHAGITIS; KRUSKAL-WALLIS TESTS; LUNG CANCER; MEAN DOSE; MEAN LUNG DOSE;

RADIOTHERAPY;

EID: 84870025729     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs056     Document Type: Article

References (11)

1. Curran WJ, Jr, Paulus R, Langer CJ et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011;103:1452-60.
2. Belderbos J, HeemsbergenW, Hoogeman M et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 2005;75:157-64. (Pubitemid 40805244)
3. ICRU. Prescribing, recording and reporting photon beam therapy. ICRU Report 50. International Commission on Radiation Units and Measurements, Bethesda MD 1993.
4. Bradley J, Deasy JO, Bentzen S et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 2004;58:1106-13. (Pubitemid 38314792)
5. Liao ZX, Komaki RR, Thames HD, Jr et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010;76:775-81.
6. Wei X, Liu HH, Tucker SL et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:100-7. (Pubitemid 44175670)
7. Werner-Wasik M, Scott C, Curran WJ, Jr et al. Correlation between acute esophagitis and late pneumonitis in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving concurrent thoracic radiotherapy (RT) and chemotherapy: A multivariate analysis of the Radiation Therapy Oncology Group (RTOG) database In: Proceedings of the 2002 ASCO Annual Meeting. Abstract 21:1192, p.299a. American Society of Clinical Oncology, Alexandria, VA, 2002.
8. Ahn S, Kahn D, Zhou S et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005;61:335-47. (Pubitemid 40164425)
9. Takeda K, Nemoto K, Saito H et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:626-9. (Pubitemid 40789937)
10. Singh AK, Lockett M, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:337-41. (Pubitemid 36069091)
11. El Naqa I, Bradley J, Blanco Al et al. Multivariable modeling of radiotherapy outcomes including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 2006;64:1275-86.